ストックスクリーナーアプリを入手
44.30
1.75%
0.745
Novo Nordisk Adr (NVO) 最新ニュース
3 Under-the-Radar Stocks to Buy and Hold for a Decade - The Motley Fool
Novo Nordisk A/ S Stock (DK0062498333): Buyback Update Puts Capital Returns In Focus - AD HOC NEWS
Novo Nordisk (NVO) repurchases 19.9M B shares under 2026 plan - Stock Titan
Novo Nordisk A/ S Stock (DK0060534915): Technical picture draws investor focus - AD HOC NEWS
Novo Nordisk A/S Stock (DK0060534915): Wegovy tablet approval and ADRs in focus after late-week gain - AD HOC NEWS
NVO Stock Quote Price and Forecast - CNN
Market news - investments.halifax.co.uk
Novo Nordisk Wegovy pill draws 10,000 UK waitlist ahead of approvalBloomberg - Investing.com Australia
Total operating expenses of Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B – BCBA:NVOD - TradingView
Assessing Novo Nordisk (NYSE:NVO) Valuation After Recent Share Weakness And GLP‑1 Growth Questions - simplywall.st
Oral GLP-1 obesity drugs see rapid early adoption, Bernstein survey shows - Investing.com Nigeria
Novo Nordisk A/S stock (DK0062498333): Ozempic boom meets fresh obesity data and US pricing debate - AD HOC NEWS
European ADRs Started The Week In The Green - Finimize
Novo Nordisk ADR's decline widens rapidly to 3.8%, hitting a new intraday low - Bitget
Novo Nordisk stock falls on ADA conference readthrough - Investing.com
Novo Nordisk Wegovy Trial With Veru Adds Underappreciated Obesity Angle - Sahm
Total operating expenses of Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B – BCBA:NVO - TradingView
Novo Nordisk A/S stock (DK0062498333): Danish pharma heavyweight steadies after recent pullback - AD HOC NEWS
Novo Nordisk launches Wegovy weight-loss pill in UAE - Investing.com
Novo Nordisk Trial Updates Test Support For Obesity And Diabetes Valuation - Sahm
Novo Nordisk’s Adiposity Franchise Under Siege as CVS Levels the Playing Field and US Pricing Rule - AD HOC NEWS
Novo Nordisk Stock Forecast | Q1 Results and Guidance - Capital.com
Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B - TradingView
US and China trade journalist expulsions in tit-for-tat moves - WPLG Local 10
Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B Trade Ideas — BCBA:NVO - TradingView
Novo Nordisk A/S (ADR) stock (DK0062498333): valuation in focus after strong run for Denmark’s pha - AD HOC NEWS
Discontinued operations of Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B – BCBA:NVO - TradingView
Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B Trade Ideas — BCBA:NVOC - TradingView
Total debt per share of Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B – BCBA:NVO - TradingView
Revenue per share of Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B – BCBA:NVO - TradingView
Book value per share of Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B – BCBA:NVO - TradingView
Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B Trade Ideas — BCBA:NVOD - TradingView
NVO News | NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) - ChartMill
Total debt of Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B – BCBA:NVOC - TradingView
Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B Cash Flow – BCBA:NVOD - TradingView
Book value per share of Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B – BCBA:NVOC - TradingView
Debt to equity ratio of Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B – BCBA:NVOC - TradingView
Average basic shares outstanding of Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B – BCBA:NVOC - TradingView
Total operating expenses of Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B – BCBA:NVOC - TradingView
Net income of Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B – BCBA:NVOC - TradingView
Caution with BioNTech! Novo Nordisk Accelerates! Buying Opportunity in Vidac Pharma Stock? - news.financial
1.06%
0.29%
大文字化:
|
ボリューム (24 時間):